Preclinical investigations and a first-in-human phase 1a trial of JS007, a novel anti-CTLA-4 antibody, in patients with advanced solid tumors

Zhou, C., Jiang, J., Xiang, X. et al. Preclinical investigations and a first-in-human phase 1a trial of JS007, a novel anti-CTLA-4 antibody, in patients with advanced solid tumors. Exp Hematol Oncol 13, 98 (2024).

Used in this study: B-hPD-1/hCTLA4 mice